Nukkleus Stock Market Value
| NUKKW Stock | 0.03 0.00 0.00% |
| Symbol | Nukkleus |
Nukkleus Price To Book Ratio
Is Application Software space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Nukkleus. If investors know Nukkleus will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Nukkleus listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.02) | Revenue Per Share 7.024 | Quarterly Revenue Growth (0.97) | Return On Assets (1.15) | Return On Equity (0.75) |
The market value of Nukkleus is measured differently than its book value, which is the value of Nukkleus that is recorded on the company's balance sheet. Investors also form their own opinion of Nukkleus' value that differs from its market value or its book value, called intrinsic value, which is Nukkleus' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Nukkleus' market value can be influenced by many factors that don't directly affect Nukkleus' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Nukkleus' value and its price as these two are different measures arrived at by different means. Investors typically determine if Nukkleus is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Nukkleus' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Nukkleus 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Nukkleus' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Nukkleus.
| 11/30/2024 |
| 12/30/2024 |
If you would invest 0.00 in Nukkleus on November 30, 2024 and sell it all today you would earn a total of 0.00 from holding Nukkleus or generate 0.0% return on investment in Nukkleus over 30 days. Nukkleus is related to or competes with Radcom, Microbot Medical, Weyco, Merit Medical, Hudson Pacific, Acco Brands, and AMCON Distributing. Nukkleus is entity of United States. It is traded as Stock on NASDAQ exchange. More
Nukkleus Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Nukkleus' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Nukkleus upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | 0.099 | |||
| Maximum Drawdown | 243.49 |
Nukkleus Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Nukkleus' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Nukkleus' standard deviation. In reality, there are many statistical measures that can use Nukkleus historical prices to predict the future Nukkleus' volatility.| Risk Adjusted Performance | 0.0895 | |||
| Jensen Alpha | 3.34 | |||
| Total Risk Alpha | 2.4 | |||
| Treynor Ratio | (10.88) |
Nukkleus Backtested Returns
Nukkleus is out of control given 3 months investment horizon. Nukkleus has Sharpe Ratio of 0.1, which conveys that the firm had a 0.1% return per unit of risk over the last 3 months. We were able to collect data for sixteen different technical indicators, which can help you to evaluate if expected returns of 3.5% are justified by taking the suggested risk. Use Nukkleus Mean Deviation of 10.79, standard deviation of 33.41, and Risk Adjusted Performance of 0.0895 to evaluate company specific risk that cannot be diversified away. Nukkleus holds a performance score of 8 on a scale of zero to a hundred. The company secures a Beta (Market Risk) of -0.31, which conveys possible diversification benefits within a given portfolio. As returns on the market increase, returns on owning Nukkleus are expected to decrease at a much lower rate. During the bear market, Nukkleus is likely to outperform the market. Use Nukkleus variance and rate of daily change , to analyze future returns on Nukkleus.
Auto-correlation | 0.00 |
No correlation between past and present
Nukkleus has no correlation between past and present. Overlapping area represents the amount of predictability between Nukkleus time series from 30th of November 2024 to 15th of December 2024 and 15th of December 2024 to 30th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Nukkleus price movement. The serial correlation of 0.0 indicates that just 0.0% of current Nukkleus price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.0 | |
| Spearman Rank Test | 1.0 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Nukkleus lagged returns against current returns
Autocorrelation, which is Nukkleus stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Nukkleus' stock expected returns. We can calculate the autocorrelation of Nukkleus returns to help us make a trade decision. For example, suppose you find that Nukkleus has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Nukkleus regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Nukkleus stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Nukkleus stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Nukkleus stock over time.
Current vs Lagged Prices |
| Timeline |
Nukkleus Lagged Returns
When evaluating Nukkleus' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Nukkleus stock have on its future price. Nukkleus autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Nukkleus autocorrelation shows the relationship between Nukkleus stock current value and its past values and can show if there is a momentum factor associated with investing in Nukkleus.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Nukkleus Stock Analysis
When running Nukkleus' price analysis, check to measure Nukkleus' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Nukkleus is operating at the current time. Most of Nukkleus' value examination focuses on studying past and present price action to predict the probability of Nukkleus' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Nukkleus' price. Additionally, you may evaluate how the addition of Nukkleus to your portfolios can decrease your overall portfolio volatility.